BioNTech SE 22UA-DE:XETRA

*Data is delayed | EUR
Last | 05/07/21 CEST
149.40quote price arrow up+10.00 (+7.17%)
Volume
485,846
52 week range
65.50 - 185.25

...

Loading . . .
  • Open147.35
  • Day High153.00
  • Day Low141.20
  • Prev Close139.40
  • 52 Week High185.25
  • 52 Week High Date05/04/21
  • 52 Week Low65.50
  • 52 Week Low Date12/29/20

Key Stats

  • Market Cap45,473.59M
  • Shares Out241.52M
  • 10 Day Average Volume475,594.91
  • Dividend-
  • Dividend Yield-
  • Beta
  • YTD % Change104.71

KEY STATS

  • Open147.35
  • Day High153.00
  • Day Low141.20
  • Prev Close139.40
  • 52 Week High185.25
  • 52 Week High Date05/04/21
  • 52 Week Low65.50
  • 52 Week Low Date12/29/20
  • Market Cap45,473.59M
  • Shares Out241.52M
  • 10 Day Average Volume475,594.91
  • Dividend-
  • Dividend Yield-
  • Beta
  • YTD % Change104.71

RATIOS/PROFITABILITY

  • EPS (TTM)-0.33
  • P/E (TTM)-452.73
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Related Video

VIDEO4:4004:40
Oppenheimer health care analyst on whether vaccine makers should lose sleep over patent waivers

Profile

MORE
BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. It develops a broad product pipeline using different scientific approaches and technology platforms, including individualized mRNA-based product candidates, chimeric antigen receptor T-cells, checkpoint immunomodulators, targeted cancer antibodies and small molecules. In addition, the Company...
Address
An der Goldgrube 12
Mainz
55131
Germany